Abstract
The discoveries of Sch 48461 and Sch 58235 and their novel pharmacology of inhibition of cholesterol absorption have prompted efforts to determine their biological mechanism of action (MOA). To this end, a series of radioiodinated analogues with good to excellent in vivo activity have been designed and synthesized as single enantiomers. They are structurally consistent with the allowable SAR of the 2-azetidinone class of cholesterol absorption inhibitors.
MeSH terms
-
Animals
-
Anticholesteremic Agents / chemical synthesis*
-
Anticholesteremic Agents / pharmacology*
-
Azetidines / chemical synthesis*
-
Azetidines / chemistry
-
Azetidines / pharmacology*
-
Cholesterol / pharmacokinetics*
-
Cricetinae
-
Drug Design
-
Ezetimibe
-
Intestinal Absorption / drug effects*
-
Isotope Labeling
-
Stereoisomerism
-
Structure-Activity Relationship
Substances
-
2-azetidinone
-
Anticholesteremic Agents
-
Azetidines
-
1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone
-
Cholesterol
-
Ezetimibe